Hourly refreshWed, Jul 22, 2026

Press Release Database

Recent press releases, indexed by topic.
Topic

Healthcare

3,196 press releases indexed under healthcare.

AllFinanceCryptoAISaaSHealthcareReal EstateEnergyRetailAutomotiveGamingMediaEducation
DownloadExcelTXT
Healthcare

Atrium Therapeutics Announces FDA Clearance of Investigational New Drug Application for ATR 1072 for Treatment of PRKAG2 Syndrome

-- ATR 1072 is the company's first precision cardiology program to enter the clinic -- -- Corventis™ will be the first clinical trial for people living with PRKAG2 syndrome that evaluates a potential treatment for the underlying cause of the disease -- SAN DIEGO, July 14, 2026...

Jul 14 · 10:30PR Newswire
Finance · AI

Haoxi Health Technology Limited Announces Strategic Cooperation Framework with NOVA MEDIA to Develop An AI Digital Marketing System

BEIJING, July 14, 2026 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), a Beijing-headquartered online marketing solutions provider specializing in one-stop digital marketing services for the health and wellness industry, today announced the signing of a strategic cooperation framework agreement with NOVA MEDIA, a technology company with expertise in AI digital humans and generative AI.

Jul 14 · 10:30GlobeNewswire
Healthcare

Medical Imaging Market Future Demand Analysis

The global medical imaging market was valued at USD 43.5 billion in 2025 and is projected to grow from USD 45.5 billion in 2026 to USD 64.7 [read full press release...]

Jul 14 · 10:21Express Press Release
Finance · Healthcare

Spero Therapeutics Announces $105 Million Non-Recourse Non-Dilutive Financing Backed by a Portion of Utebzi Milestones & Royalties

CAMBRIDGE, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced a $105 million non-recourse non-dilutive royalty financing transaction with affiliates of Healthcare Royalty, a business of KKR (HCRx). Under the agreement, HCRx will receive a portion of future milestone and royalty payments associated with sales of Utebzi™ (tebipenem pivoxil). The proceeds will primarily be used to support advancement of Spero’s lead immunology drug candidate, SP001, a Phase 2-ready, Fc-silent, third-generation anti-CD40L monoclonal antibody with potential for development across a range of immune-mediated diseases.

Jul 14 · 10:02GlobeNewswire
Healthcare · Education

"Nursing is for Me, Mom - What's Next?" from LA Fridlington Introduces Young Readers to the Diverse Career Pathways Available Within the Nursing Profession

LA Fridlington has completed a new book, "Nursing is for Me, Mom - What's Next?: Teddy Learns about the Many Roles of a Nurse," which follows Teddy's journey through a school career fair where an engaging nurse mentor reveals the breadth of opportunities in healthcare. Through this narrative, readers discover that nursing extends far beyond hospital walls—into community settings, traveling positions, and [PR.com]

Jul 14 · 10:00PR.com
Healthcare · Education

Legacy Youth Zone Golf Day Raises Over £80,000 for Young People Across Croydon

Tuesday 14 July, 2026 Legacy Youth Zone Croydon is delighted to announce that its annual Golf Day, organised by Trustee Indy Chatwal, Managing Director of I See Apps, has raised more than £80,000 to support thousands of local young people. Held on Wednesday 24 June at the prestigious The Addington Golf Course, the event brought together more than 100 golfers, local business leaders, supporters and sponsors for a day of sport, networking and fundraising in aid of Legacy Youth Zone’s life-changing work. The headline sponsor was from Modern Health Group for the day alongside other sponsors including: BootBuddy, Roasting Party, Bradley & Sons, Whisky Brokers Associates, Live Mauritius, Quilter, Namos Solutions, PMJ Risk Solutions, Sherrards, Roley’s, HotBoss, TW Drainage and Mobsta. The event

Jul 14 · 09:54Pressat
Finance · Healthcare

HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction

CHENGDU, China, July 14, 2026 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH), congratulates its partner BioAge Labs, Inc. ("BioAge", NASDAQ: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for...

Jul 14 · 08:30PR Newswire
Healthcare

Phase II Trial of Cadonilimab(PD-1/CTLA-4) Combination Regimen Launches in the United States for Perioperative Treatment of Gastric Cancer

HONG KONG, July 14, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that it has entered into a collaboration with Memorial Sloan Kettering Cancer Center (MSKCC) to advance a Phase II clinical study evaluating a cadonilimab-based combination regimen...

Jul 14 · 08:18PR Newswire
AI · Healthcare

RWS launches new linguistic validation service to significantly reduce clinical trial timelines

New service brings critical eCOA trial services together under one program team to speed global studies MAIDENHEAD, England, July 14, 2026 /PRNewswire/ -- RWS (AIM: RWS.L), a global AI solutions company, today launched a new tech-enabled eCOA translation and linguistic validation service...

Jul 14 · 08:01PR Newswire
SaaS · Healthcare

Hennick Humber Hospital in Canada has selected Sectra One Cloud to speed up patient diagnostics with improved radiology workflows

LINKÖPING, Sweden and MISSISSAUGA, ON, July 14, 2026 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its fully managed, cloud enterprise imaging solution, Sectra One Cloud, to Hennick Humber Hospital (HHH) in Canada. This SaaS...

Jul 14 · 07:14PR Newswire
Healthcare

Biovica Receives Ninth Work Order From a Leading Global Pharmaceutical ...

(PR-inside.com) UPPSALA, SE / ACCESS Newswire / July 14, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a company specializing in blood-based cancer monitoring, today announced that it has received a new work order from a current customer, one of the world's leading pharmaceutical companies with a strong oncology pipeline. This marks the ninth work order received from the same customer, further strengthening the ongoing collaboration. The work order covers DiviTum® TKa testing services for a clinical breast cancer study evaluating a next-generation CDK inhibitor in combination with endocrine therapy. The study includes serial TKa testing over a period of up to four ..

Jul 14 · 07:10PR-Inside
Healthcare

Breakout Wellness UK Empowers the Next Generation of Wellness Innovators

A new accelerator programme from Growth Studio will support ambitious founders building the UK's next generation of health and wellness brands. LONDON, July 14, 2026 /PRNewswire/ -- Growth Studio has today announced the launch of Breakout Wellness UK - a new accelerator programme designed...

Jul 14 · 06:15PR Newswire
← Prev123267Next →